Academic Journal
Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility study
| العنوان: | Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility study |
|---|---|
| المؤلفون: | Passardi, Alessandro, Rizzo, Mimma, Maines, Francesca, Tondini, Carlo, Zambelli, Alberto, Vespignani, Roberto, Andreis, Daniele, Massa, Ilaria, Dianti, Marco, Forti, Stefano, Piras, Enrico Maria, Eccher, Claudio |
| المصدر: | BMJ Open ; volume 7, issue 5, page e014617 ; ISSN 2044-6055 2044-6055 |
| بيانات النشر: | BMJ |
| سنة النشر: | 2017 |
| الوصف: | Introduction Despite the growing number of oral agents available for cancer treatment, their efficacy may be reduced due to the lack of adherence, inappropriate adverse event self-management and arbitrary dose adjustment. The management of anticancer therapies could exponentially benefit from the introduction of mobile health technologies in a highly integrated electronic oncology system. Methods and analysis We plan to customise and fine-tune an existing monitoring TreC platform used in different chronic diseases in the oncology setting. This project follows a multistep approach with two major purposes: 1. participatory design techniques driven by Health Literacy and Patient Reported Outcomes principles in order to adapt the system to the oncology setting involving patients and healthcare providers; 2. a prospective training-validation, interventional, non-pharmacological, multicentre study on a series of consecutive patients with cancer (20 and 60 patients in the training and validation steps, respectively) in order to assess system capability, usability and acceptability. The novel Onco-TreC 2.0 is expected to contribute to improving the adherence and safety of cancer care, promoting patient empowerment and patient–doctor communication. Ethics and dissemination Ethical approval was obtained from the Independent Ethics Committees of the participating institutions (CEIIAV protocol Number 2549/2015; reference Number 1315-PU). Informed consent will be obtained from all study participants. Findings will be disseminated through peer-reviewed journals, conferences and event presentations. Trial registration number ClinicalTrials.gov ( NCT02921724 ); (Pre-results). Other study ID Number: IRST100.18. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1136/bmjopen-2016-014617 |
| الاتاحة: | http://dx.doi.org/10.1136/bmjopen-2016-014617 https://syndication.highwire.org/content/doi/10.1136/bmjopen-2016-014617 |
| رقم الانضمام: | edsbas.23A8793B |
| قاعدة البيانات: | BASE |
| DOI: | 10.1136/bmjopen-2016-014617 |
|---|